Labceutics to Conduct Pan European Quality Assurance Study on Standardization of BCR-ABL1 Testing to Improve Patient Management in CML BELFAST, UNITED KINGDOM--(Marketwire - Mar 12, 2013) - Labceutics Inc. announced today that it has partnered with Asuragen Inc., a leading molecular diagnostics company, to conduct an international...

New Website Highlights Diaceutics Leadership in Personalized Medicine-Focused Consulting and Software Applications BELFAST, UNITED KINGDOM--(Marketwire - Jul 23, 2012) - Diaceutics today announced the re-launch of the company's website (www.diaceutics.com) with numerous new features and resources. Diaceutics...

Labceutics Launches "Labceutics Connect" Platform LONDON--(Marketwire - Jun 19, 2012) - Labceutics (www.labceutics.com), the leading personalized medicine laboratory network in the EU, has launched the Labceutics ConnectÔ platform. Labceutics...

Laboratories Essential to Success of Personalised Medicine, but Often Forgotten by Pharmaceutical Industry, According to New Survey by Labceutics LONDON--(Marketwire - Feb 28, 2012) - Laboratories performing molecular or genetic diagnostic testing play a vital strategic role in the success of personalized medicine (PM), but are often the...

Diaceutics Launches Labceutics Laboratory Network in Europe in Support of Growing Personalized Medicine Market LONDON--(Marketwire - Sep 13, 2011) - Diaceutics (www.diaceutics.com) announced today the launch of Labceutics (www.labceutics.com), a new laboratory network to service the growing personalized...